A doxorubicin prodrug designed to be cleaved by prostate specific antigen (PSA) is effective in a mouse model of prostate carcinoma, according to a report in the March 1st International Journal of Cancer. Reuters Health Information
Inhibition of the signal transducer and activator of transcription 5a/b (Stat5a/b), the key mediator of prolactin effects in prostate cancer cells, kills cancer cells and inhibits xenograft growth in mice, researchers report in the March 1st issue of Clinical Cancer Research. Reuters Health Information
Dietary potassium seems to protect against the vascular damage seen with salt-sensitive hypertension, at least in part by suppressing the generation of reactive oxygen species, according to a Japanese study. Reuters Health Information
US researchers have developed regulatory T cells that are capable of suppressing multiple sclerosis and other autoimmune diseases in mice, according to a report in the March 24th Early Edition of the Proceedings of the National Academy of Sciences. Reuters Health Information
Homozygosity at certain "hot spot" gene locations appears to play an important role in cancer susceptibility, scientists at the Cleveland Clinic Foundation report in the Journal of the American Medical Association for March 26. Reuters Health Information
New research suggests that endothelial nitric oxide synthase (eNOS) plays a key role in Ras signaling pathways and could serve as a therapeutic target. Reuters Health Information
New research into the genetic underpinnings of schizophrenia implicates rare mutations that prevent normal brain development, according to a report in the March 27th online issue of Science. Reuters Health Information
British researchers say they have created embryos and stem cells using human cells and oocytes of cows, but said such experiments would not lead to hybrid human-animal babies, or even to direct medical therapies. Reuters Health Information
In contrast to most prior studies, a new study suggests that carrying the apolipoprotein epsilon 4 (APOE-e4) allele may have a protective influence on long-term outcome following traumatic brain injury. Reuters Health Information
Inhibition of the mammalian target of rapamycin (mTOR) pathway by everolimus works in concert with epithelial growth factor receptor (EGFR) inhibitors in human tumors both sensitive and resistant to anti-EGFR drugs, according to Italian researchers. Reuters Health Information